Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...
Vancouver city council ordered the demolition of the building at 500 Dunsmuir St. in December 2024, after an inspection found it was at risk of collapse.